. 2023 Sep 27;42(5):649–659. doi: 10.23876/j.krcp.22.240

Table 5.

Factors associated with death in KRT patients with COVID-19 infection

Factor	Crude OR (95% CI)	p-value	Adjusted OR^b (95% CI)	p-value
Age	1.03 (1.03–1.04)	<0.001	1.03 (1.02–1.04)	<0.001
Male^a	1		1
Female	0.96 (0.81–1.13)	0.60	0.85 (0.71–1.02)	0.08
Diabetes	1.63 (1.35–1.96)	<0.001	1.26 (1.03–1.53)	0.03
Cardiovascular disease	1.64 (1.38–1.94)	<0.001	1.44 (1.20–1.72)	<0.001
Cerebrovascular disease	1.33 (1.06–1.67)	0.01	1.16 (0.92–1.47)	0.20
Malignancy	0.97 (0.62–1.48)	0.90	0.90 (0.56–1.39)	0.60
Hypertension	1.45 (0.92–2.38)	0.12	0.96 (0.60–1.62)	0.90
Airway disease	0.91 (0.68–1.20)	0.50	0.76 (0.56–1.02)	0.07
Liver disease	1.01 (0.80–1.26)	>0.90	0.99 (0.78–1.25)	0.90
HIV	1.36 (0.30–4.57)	0.60	1.39 (0.28–5.42)	0.70
Psychiatric problem	1.59 (1.16–2.16)	0.003	1.15 (0.83–1.59)	0.40
Mode of KRT
HD^a	1		1
KT	0.34 (0.15–0.66)	0.004	0.51 (0.22–1.04)	0.09
PD	0.83 (0.70–0.98)	0.03	0.85 (0.71–1.02)	0.09
No. of vaccination doses
No vaccination^a	1		1
Single dose	0.77 (0.63–0.93)	0.007	0.71 (0.58–0.87)	<0.001
Double dose	0.31 (0.22–0.43)	<0.001	0.30 (0.21–0.42)	<0.001
At least three doses	0.26 (0.01–1.29)	0.20	0.28 (0.02–1.44)	0.20
Type of vaccine without mRNA^a	1		1
With mRNA	2.68 (1.18–7.73)	0.04	1.50 (0.63–4.42)	0.40
Interval between the last vaccination and admission date (day)	0.99 (0.98–0.99)	<0.001	0.99 (0.98–0.99)	<0.001

CI, confidence interval; COVID 19, coronavirus disease 2019; HD, hemodialysis; HIV, human immunodeficiency virus; KT, kidney transplantation; KRT, kidney replacement therapy; mRNA, messenger RNA; OR, odds ratio; PD, peritoneal dialysis.

Reference to calculate ORs.

Adjusted for age, sex, diabetes, cardiovascular disease, cerebrovascular disease, malignancy, hypertension, airway disease, liver disease, HIV, psychiatric problems, mode of KRT, number of vaccination doses, types of vaccine, and interval between the date of the last vaccination and the date of hospital admission due to COVID-19 infection.